Status:
COMPLETED
Osteoporosis Disease Management Demonstration Project (0000-037)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Osteoporosis
Eligibility:
FEMALE
65-89 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.
Eligibility Criteria
Inclusion
- Members of the Henry Ford Health System
Exclusion
- Individuals who are not members of the Henry Ford Health System
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT00139425
Start Date
May 1 2003
End Date
December 1 2004
Last Update
April 22 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.